HOME >> MEDICINE >> NEWS
NIH convenes State-of-the-Sceince Conference on Improving End-of-Life Care

The National Institutes of Health (NIH) will hold a State-of-the-Science Conference on Improving End-of-Life Care, December 6-8, 2004 at the Natcher Conference Center on the NIH campus in Bethesda, Maryland. A press briefing will be held at the close of the conference, at 2:00 p.m. on Wednesday, December 8.

Improvements in medical science and health care have gradually changed the nature of dying. Death is no longer likely to be the sudden result of infection or injury, but is now more likely to occur slowly, in old age, and at the end of a period of chronic illness. As a result, a demographic shift is beginning to occur that will include an increase in the number of seriously ill and dying people at the same time that the number of caregivers decreases. These ongoing changes present a number of quality-of-care issues that will impact the healthcare system.

This conference will bring together researchers and practitioners in various aspects of end-of-life care and research, to examine and synthesize the scientific evidence available to answer five key conference questions:

  • What defines the transition to end of life?
  • What outcome variables are important indicators of the quality of the end of life experience for the dying person and for the surviving loved ones?
  • What patient, family, and health care system factors are associated with improved or worsened outcomes?
  • What processes and interventions are associated with improved or worsened outcomes?
  • What are future research directions for improving end-of-life care? During the first day and part of the second day of the conference, experts will present the latest findings in end-of-life research to an independent panel. The panel will then meet in executive session to weigh the evidence before them and prepare its statement assessing the state of the science. The panel will present its draft statement for public comment at 9:00 a.m. on Wedne
    '"/>


  • Contact: Kelli Marciel
    marcielk@od.nih.gov
    301-496-4819
    NIH/Office of the Director
    29-Nov-2004


    Page: 1 2

    Related medicine news :

    1. Hopkins convenes consensus conference to develop blueprint for nationwide matching program
    2. Science of better convenes operations researchers in Denver
    3. NIH convenes state-of-the-science conference on preventing youth violence
    4. NIH convenes Consensus Development Conference on Total Knee Replacement
    5. Worlds largest scientific society convenes regional meeting May 30 - June 2 in Chicago
    6. Chemical society convenes regional meeting in Lawrence, Kan., Oct. 23-25
    7. NIH convenes workshop on menopausal hormone therapy
    8. Chemical society convenes regional meeting in San Antonio, October 17-20
    9. Conference convenes on ibogaine, a controversial drug to treat heroin addiction
    10. ESMO Scientific & Educational Conference (ESEC)
    11. Press advisory: White House Conference on Aging Forum

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    TAG: NIH convenes State the Sceince Conference Improving End Life Care

    (Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... been developed that changes color when subjected to an impact force that is great ... be implemented in helmets or other sporting equipment so that coaches or officials would ...
    (Date:9/4/2015)... ... September 04, 2015 , ... According to an article published August ... Association presented data showing that it is safe for pregnant women to undergo local ... had undergone local anesthesia with a group that hadn’t, researchers were able to determine ...
    (Date:9/4/2015)... ... September 04, 2015 , ... On ... has effectively doubled the size of its annual health tech innovation program. Now ... digital health startups to compete for cash and prizes to advance their technologies ...
    (Date:9/4/2015)... , ... September 04, 2015 , ... With TransCel from ... mouse all within Final Cut Pro X. With TransCel users have full control over ... width, background color, speed method, frame color, inner color, text, and more. With TransCel ...
    (Date:9/4/2015)... ... 2015 , ... Mile High Connects today releases “First and Last Mile Connections,” ... sidewalks, bike paths, and other vital supports severely limit access to public transportation for ... dollars to expand public transit, there’s very little support for safe and convenient access ...
    Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Missed Connections in Metro Denver Transit 2
    (Date:9/4/2015)... , Sept. 4, 2015  Janssen Research & ... and Drug Administration (FDA) has accepted for Priority ... as a treatment for patients with multiple myeloma ... (PI) and an immunomodulatory agent (IMiD), or who ... therapy, including a PI and an IMiD. This ...
    (Date:9/4/2015)... -- Fair Rate Funding, a lawsuit funding firm located in ... increase in lawsuit filings in connection with the blood thinning ... Philadelphia Court of Common Pleas has ... Louisiana multi---district litigation (MDL), located in ... Louisiana , the filings are also on the ...
    (Date:9/4/2015)... HILL, N.C. , Sept. 4, 2015 /PRNewswire/ ... Liaisons (MSLs) and other Field-Based Medical Specialists (FBMS) ... key opinion leaders, and thought leaders in critical ... effectiveness of their field-based teams, companies are expanding ... order to align countries with corporate objectives and ...
    Breaking Medicine Technology:U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2
    Cached News: